NYAS Workshop: Risky Business — The Future of Biopharmaceutical Innovation
Biopharmaceutical companies make some of the biggest and most risky gambles of any industry: each new drug ultimately requires multi-billion-dollar investments. These investments take more than a decade to play out — during which time, profound changes will occur. Internal portfolios wax and wane; competitors’ innovations, regulatory & commercial frameworks reshape the playing field; some therapeutic advancements move the pitch to a new field altogether.
In such an uncertain landscape, companies are constantly rethinking their strategy, and how they can try and take advantage of technical advancements to build innovation models that are fit for the future. With the emergence of open innovation networks, what will be the role for in-house R&D?
This “gameified” event gives scientists an understanding of how biopharma innovation dynamics evolve. Through a specially developed game, teams compete under decision-making pressure to develop and bring new drugs to market. It’s a fun way to spend a winter Saturday with friends and meet new colleagues! Reception follows directly after workshop.
For full event details and to register, visit The New York Academy of Sciences website.
